Insights

Acquisition by Ipsen Epizyme was recently acquired by Ipsen, expanding Ipsen's oncology portfolio. This acquisition presents an opportunity for cross-selling products or services to the newly merged entity.

Strong Financial Performance Epizyme reported a positive financial performance in the second quarter, exceeding revenue estimates. This indicates potential demand for complementary services or solutions from vendors or partners.

Clinical Advancements Epizyme focuses on developing transformative therapies for cancer patients through novel epigenetic targets. Companies offering supportive technologies or services in this area could find opportunities for collaboration or sales.

Commercial-stage Biopharma Epizyme operates as a commercial-stage biopharmaceutical company, implying a readiness to scale and a potential need for supplementary services, such as logistics, distribution, or marketing support.

High Revenue Growth Potential Epizyme's revenue growth potential is underscored by beating revenue estimates and ongoing research advancements. This growth trajectory can signal opportunities for partnerships, licensing deals, or sales of innovative solutions to support their expansion.

Similar companies to Epizyme

Epizyme Tech Stack

Epizyme uses 8 technology products and services including Hyperion, Oracle, IQVIA, and more. Explore Epizyme's tech stack below.

Hyperion
Corporate Performance Management
Oracle
Enterprise
IQVIA
Health Platform
Google
Miscellaneous
Office 365
Office Suites
Boomi
Platform As A Service
Yoast SEO
Search Engines
Nginx
Web Servers

Media & News

Epizyme's Email Address Formats

Epizyme uses at least 1 format(s):

Epizyme Email Formats	Example	Percentage
FLast@epizyme.com	JDoe@epizyme.com	89%
Last@epizyme.com	Doe@epizyme.com	9%
FL@epizyme.com	JD@epizyme.com	1%
First_L@epizyme.com	John_D@epizyme.com	1%

Frequently Asked Questions

Where is Epizyme's headquarters located?

Epizyme's main headquarters is located at 400 Technology Square 4th floor Cambridge, MA 02139 US. The company has employees across 2 continents, including North AmericaEurope.

What is Epizyme's phone number?

You can contact Epizyme's main corporate office by phone at

+1-617-229-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Epizyme's stock symbol?

Epizyme is a publicly traded company; the company's stock symbol is EPZM.

What is Epizyme's official website and social media links?

Epizyme's official website is epizyme.com and has social profiles on LinkedIn.

What is Epizyme's SIC code NAICS code?

Epizyme's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 446110 - Pharmacies and Drug Stores.

How many employees does Epizyme have currently?

As of March 2022, Epizyme has approximately 246 employees across 2 continents, including North AmericaEurope. Key team members include Chief Strategy And Business Officer: M. R.Chief Of Staff, Clinical Development: A. J. B.Vice President Finance: D. M.. Explore Epizyme's employee directory with LeadIQ.

What industry does Epizyme belong to?

Epizyme operates in the Biotechnology Research industry.

What technology does Epizyme use?

Epizyme's tech stack includes HyperionOracleIQVIAGoogleOffice 365BoomiYoast SEONginx.

What is Epizyme's email format?

Epizyme's email format typically follows the pattern of . Find more Epizyme email formats with LeadIQ.

When was Epizyme founded?

Epizyme was founded in 2007.

Epizyme

Biotechnology ResearchMassachusetts, United States201-500 Employees

Epizyme is dedicated to rewriting treatment for people with cancer through targeted epigenetic medicines. We aspire to change the standard of care for patients and physicians by developing medicines with fundamentally new mechanisms of action directed at specific causes of hematological malignancies and solid tumors. 
 
Our research is yielding exciting new targets for which we are developing novel small molecule programs with the goal of expanding on a pipeline of clinical candidates. Our exceptional team is dedicated to bringing epigenetic therapies to the many patients who need them. Learn more at www.epizyme.com.
 
For our community guidelines, visit https://epzy.me/communityguidelines.